business / news / / Reuters
Shares of the healthcare conglomerate rose 4% before the bell.
CVS raised its 2026 profit forecast to $7.30–$7.50 per share, up from $7.00–$7.20.
KEY POINTS
- CVS' Aetna insurance medical loss ratio was 84.6%, notably lower than analysts’ 87.58% estimate.
- CVS acquired Rite Aid pharmacies, gaining 9 million new customers after completing the deal.
- Despite revenue growth, CVS pharmacy operating income fell 8.8% due to regulatory and weather impacts.
- CVS’ Caremark pharmacy benefit manager earnings increased due to a more profitable drug mix.
COMPANIES
Summarized by Newsio from Reuters. How we summarize →